FMCG Gurus – Weight Loss Medication in UK – Country Report – 2025
Report Description:
Over the past year, FMCG Gurus has explored the emerging impact of GLP-1 weight loss medication on consumer behavior towards food and drink. As interest in GLP-1 medication intensifies, especially among consumers seeking faster solutions to manage their weight, brands must understand how this trend could disrupt traditional dietary behaviors.
This report examines perceptions, usage and challenges around weight loss medication. It also explores the lifestyle changes of consumers using this medication, side effects and perceived effectiveness. The report also looks at interest in food and drink that naturally stimulates GLP-1 hormones.
This report will look at the following areas:
- Awareness and perceptions of GLP-1 medication, including perceived efficacy and risks.
- Overall usage of GLP-1 medication and length of usage.
- Additional steps that users have taken to improve their overall health and lifestyle.
- Side effects that consumers have experienced while using weight loss medication and how this has affected usage.
- How effective consumers feel that this medication has been in the long-term.
- The type of regulation that consumers would like to see around weight loss medication.
- Consumer interest in food and drink that stimulates GLP-1 medication.
- Actions and recommendations for targeting the weight loss medication market.
FMCG Gurus – Weight Loss Medication in UK – Country Report – 2025
Report Description:
Over the past year, FMCG Gurus has explored the emerging impact of GLP-1 weight loss medication on consumer behavior towards food and drink. As interest in GLP-1 medication intensifies, especially among consumers seeking faster solutions to manage their weight, brands must understand how this trend could disrupt traditional dietary behaviors.
This report examines perceptions, usage and challenges around weight loss medication. It also explores the lifestyle changes of consumers using this medication, side effects and perceived effectiveness. The report also looks at interest in food and drink that naturally stimulates GLP-1 hormones.
This report will look at the following areas:
- Awareness and perceptions of GLP-1 medication, including perceived efficacy and risks.
- Overall usage of GLP-1 medication and length of usage.
- Additional steps that users have taken to improve their overall health and lifestyle.
- Side effects that consumers have experienced while using weight loss medication and how this has affected usage.
- How effective consumers feel that this medication has been in the long-term.
- The type of regulation that consumers would like to see around weight loss medication.
- Consumer interest in food and drink that stimulates GLP-1 medication.
- Actions and recommendations for targeting the weight loss medication market.
How This Report Can Benefit the Industry:
- Identify opportunities to innovate and reposition products in a shifting weight-management market.
- Understand the emerging risks and reputational challenges tied to the medicalization of weight loss.
- Anticipate how consumer behavior will change and how best to adapt to accomodate for these changes.
Files included in this report:
FMCG-Gurus-Weight-Loss-Medication-in-the-UK-Country-Report-2025.pdf
FMCG-Gurus-Weight-Loss-Medication-in-the-UK-Country-Report-2025.pptx